Comment on: "Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer Therapy".
作者信息
Tian Tian
机构信息
Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
出版信息
Mol Pharm. 2023 Feb 6;20(2):1447-1448. doi: 10.1021/acs.molpharmaceut.2c00903. Epub 2022 Dec 28.
Abstract
摘要
Zotero 插件